Endovia Health Sciences (EDVA) Interest & Investment Income (2012 - 2024)
Analysis
Endovia Health Sciences (EDVA) Interest & Investment Income (2012 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.92 Bn | 133.07 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.02 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.96 Bn | 59.78 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.31 Bn | 52.17 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.51 Bn | 32.21 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.21 Bn | 27.37 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Endovia Health Sciences | 815,264.74 | 572,562.74 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 420.00 |
| Sep 30, 2024 | 736.00 |
| Jun 30, 2024 | 503.00 |
| Mar 31, 2024 | 332.00 |
| Dec 31, 2023 | 966.00 |
| Sep 30, 2023 | 348.00 |
| Jun 30, 2023 | 1,320.00 |
| Dec 31, 2022 | 3,201.00 |
| Sep 30, 2022 | 158.00 |
| Jun 30, 2022 | 2,709.00 |
| Dec 31, 2021 | 1.00 |
| Sep 30, 2021 | 527.00 |
| Jun 30, 2021 | 1.00 |
| Mar 31, 2021 | 114.00 |
| Dec 31, 2020 | -32,702.00 |
| Sep 30, 2020 | 16,354.00 |
| Jun 30, 2020 | 205.00 |
| Mar 31, 2020 | 16,151.00 |
| Dec 31, 2019 | -220.00 |
| Sep 30, 2019 | 320.00 |